GLOBVAC Projects

The primary objective of the Global health and vaccination research programme (GLOBVAC) is to support high-quality research with potential for high impact that can contribute to sustainable improvements in health and health equity for poor people in low- and lower-middle income countries.

Main content

Centre for International Health has a number of projects in the GLOBVAC programme from the Research Council of Norway. Learn more about the various projects here.

Photo:

Colourbox

Projects and news

RISE

Research Initiative to Support the Empowerment of girls

Umbilical Cord Cleansing for the Prevention of Newborn Infections in Uganda

Ninety-eight percent of the approximately 3.3 million deaths in the first 28 days of life occur in low and middle income countries (LMICs), yearly. A third of these are associated with infections and this proportion rises in areas where at least half of the births occur at home like Uganda.

Enfance Africaine - Mental child health in francophone Africa

In sub-Saharan Africa, few studies have looked at the diet as an important determinant of cognitive functioning and mental health among children.

Development of a vaccine for enterotoxigenic E. coli based on the heat-stable toxin

Enterotoxigenic E. coli (ETEC) expressing the heat-stable toxin (ST) is among the most important causes of diarrheal disease in children less than 5 years of age in low- and middle-income countries.

Map over the African countries: Malawi, Uganda and Kenya

Malaria Chemoprevention for the post-discharge management of severe anaemia in children in Malawi, Uganda and Kenya

The main objectives of this project are to evaluate whether it is safe and efficacious to routinely prevent malaria by giving antimalarial drugs during the first three months after discharge from hospital.

Impact of vitamin B12 on neurodevelopment and cognitive function

This project consists of previously conducted randomized, placebo-controlled trials in India and Tanzania, where half of the participants received high doses of vitamin B12 in early life.

Zinc as an adjunct for the treatment of very severe disease in infants

More than 3 of the 7.6 million global deaths in under 5 years occur in the neonatal period and about 75% in the first week of life. More than 70% of these neonatal deaths occur in Africa and South East Asia.

SeeTheChild - Mental child health in Uganda

This research project will follow-up children in the cohort established through the PROMISE EBF cluster randomized trial in Burkina Faso and Uganda in the period 2006-2008 that RCN co-funded.

This project aims to evaluate the combined effect of indoor residual spraying...

Combining indoor residual spraying and long-lasting insecticidal nets for preventing malaria

This research aims to improve malaria control by evaluating the combined effect of indoor residual spraying (IRS) and long-lasting insecticidal nets (LLINs) on malaria incidence in Ethiopia.

Improving diagnosis of extrapulmonary TB

Alarming global tuberculosis (TB) situation makes it evident that TB control needs new tools.

Poster Award at GLOBVAC 2017 Conference

Clorhexidine-study was awarded the prize for best poster at the GLOBVAC-conference 2017

Ilustrasjonsbilde Globvac forskningsrådet

Mid-term evaluation of the GLOBVAC programme

The evaluation team finds that the GLOBVAC programme has made significant achievements in a number of areas and fills an important gap in the Norwegian funding landscape.

Research Council of Norway visits GLOBVAC in Ethiopia

The Research Council of Norway (RCN) visited Ethiopia, one of its prioritized focus countries for Norwegian development cooperation, to see 6 of its Programme for Global Health and Vaccination Research (GLOBVAC) projects first-hand.

Girls from Zambia teach other youth about their right to education. Photo: Jessica Lea/DFID (Flickr, CC license)

CISMAC study in Zambia receives GLOBVAC funding

The study will examine links between adolescent pregnancies and different approaches to empower adolescent girls in Zambia.

28.11.2023